Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, February, 2010, PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period December 2009 to February 2010 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period December 2009 to February 2010 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

Actelion Tracleer PAH Succinct Healthcare Communications
Anglian Pharma Replens MD and RepHresh Vaginal health Woolley Pau PR
Basilea New product Dermatology Signature Healthcare Communications
Biotest AG New product Rheumatology 4C Consultants International
Cranage Healthcare International New product Dermatology Signature Healthcare Communications
Galderma New product Aesthetics Signature Healthcare Communications
GSK ReQuip XL Parkinson's disease Succinct Healthcare Communications
GSK Centre of Excellence New product Oncology Succinct Healthcare Communications
GSK Centre of Excellence Tyverb  Oncology Succinct Healthcare Communications
NHS Blood and Transplant (NHSBT) Ethnic marketing N/A Media Moguls
NHS Hastings & Rother Awareness campaign Cancer  Spink
Norgine New product Gastroenterology  4C Consultants International
Novartis General  Diabetes  JYC Global
sanofi-aventis New products Oncology  Succinct Healthcare Communications
Sirtex SIR-Spheres Microspheres Oncology  Succinct Healthcare Communications

 

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

26th March 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics